Governmental Plan 2022 Compliance Guide Employee Benefits Governmental Plan 2022 Compliance Guide 07/19/22 Governmental Plan 2022 Compliance Guide
Health Plan Transparency Compliance: Written Agreements with Insurance Carriers, Third-Party Administrators or Pharmacy Benefit Managers Employee Benefits Health Plan Transparency Compliance: Written Agreements with Insurance Carriers, Third-Party Administrators or Pharmacy Benefit Managers 07/13/22 Health Plan Transparency Compliance: Written Agreements with Insurance Carriers, Third-Party Administrators or Pharmacy Benefit Managers
Well-Being 3.0 – Aligning Well-Being with People and Boardroom Priorities Employee Benefits Well-Being 3.0 – Aligning Well-Being with People and Boardroom Priorities 07/13/22 Well-Being 3.0 – Aligning Well-Being with People and Boardroom Priorities
Delayed Preventive Care – How This Silent Phenomenon Is Impacting Your Workforce Employee Benefits Delayed Preventive Care – How This Silent Phenomenon Is Impacting Your Workforce 07/13/22 Delayed Preventive Care – How This Silent Phenomenon Is Impacting Your Workforce
Supreme Court Resolves Circuit Split Regarding Whether Dialysis Limitations Are Barred by the Medicare Secondary Payer Act Employee Benefits Supreme Court Resolves Circuit Split Regarding Whether Dialysis Limitations Are Barred by the Medicare Secondary Payer Act 07/12/22 Supreme Court Resolves Circuit Split Regarding Whether Dialysis Limitations Are Barred by the Medicare Secondary Payer Act
Brown & Brown’s Investment in GRP Has Won The Insurance Post “Industry Impact Award” Company News Brown & Brown’s Investment in GRP Has Won The Insurance Post “Industry Impact Award” 07/08/22 Brown & Brown’s Investment in GRP Has Won The Insurance Post “Industry Impact Award”
Commercial Insurance Market Trends Report – Q3 2022 Market Trends Commercial Insurance Market Trends Report – Q3 2022 07/06/22 Commercial Insurance Market Trends Report – Q3 2022
Will Biosimilars Disrupt Specialty Drug Spend? Employee Benefits Will Biosimilars Disrupt Specialty Drug Spend? 06/24/22 Will Biosimilars Disrupt Specialty Drug Spend?